Century Therapeutics (NASDAQ:IPSC) is a biotechnology firm focused on developing innovative therapies to improve the outcomes of cancer patients. Specializing in cellular therapies, Century Therapeutics is pioneering the development of products with the potential to treat not only hematologic cancers but also solid tumors. The company's projects leverage cutting-edge iPSC (induced pluripotent stem cell) technology to manufacture cell therapies that are more effective, accessible, and easier to produce than traditional methods. With a commitment to revolutionizing cancer treatment, Century Therapeutics aims to advance its clinical programs and expand its pipeline to address a broad range of cancers, ultimately striving to bring novel, life-saving treatments to the market.